Carregant...
Network Pharmacology-Based and Experimental Identification of the Effects of Quercetin on Alzheimer’s Disease
Alzheimer’s disease (AD) is one of the neurodegenerative brain disorders inducing nearly half of dementia cases, and the diagnosis and treatment of AD are the primary issues clinically. However, there is a lack of effective biomarkers and drugs for AD diagnosis and therapeutics so far. In this study...
Guardat en:
| Publicat a: | Front Aging Neurosci |
|---|---|
| Autors principals: | , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7645061/ https://ncbi.nlm.nih.gov/pubmed/33192484 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnagi.2020.589588 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|